Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differences in NSAID tolerability profiles. Fact or fiction?

× No keyword cloud information.

130 in total

1. Erythema multiforme bullosum following phenylbutazone treatment for arthritis; report of a fatal case.

Authors: R B CONE; C A HANNIGAN; R TEICHER
Journal: AMA Arch Derm Syphilol Date: 1954-06

2. Stevens-Johnson syndrome and granulocytopenia after phenylbutazone.

Authors: S J STEEL; J L MOFFATT
Journal: Br Med J Date: 1954-04-03

3. Hepatic and renal tolerability of long-term naproxen treatment in patients with rheumatoid arthritis.

Authors: R Turner
Journal: Semin Arthritis Rheum Date: 1988-02 Impact factor: 5.532

4. Conjunctivitis due to ketoprofen.

Authors: E M Umez-Eronini
Journal: Lancet Date: 1978-09-30 Impact factor: 79.321

Review 5. The propionic acids: a personal perspective.

Authors: S S Adams
Journal: J Clin Pharmacol Date: 1992-04 Impact factor: 3.126

6. Chronic salicylate administration in juvenile rheumatoid arthritis: aspirin "hepatitis" and its clinical significance.

Authors: J G Schaller
Journal: Pediatrics Date: 1978-11 Impact factor: 7.124

Review 7. Renal toxicity of the nonsteroidal anti-inflammatory drugs.

Authors: M D Murray; D C Brater
Journal: Annu Rev Pharmacol Toxicol Date: 1993 Impact factor: 13.820

8. Aspirin-induced depression of renal function.

Authors: R P Kimberly; P H Plotz
Journal: N Engl J Med Date: 1977-02-24 Impact factor: 91.245

9. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males.

Authors: I L Salom; G Jacob; N Jallad; C A Perdomo; J F Mullane; D Weidler
Journal: J Clin Pharmacol Date: 1984 May-Jun Impact factor: 3.126

10. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs.

Authors: M C Allison; A G Howatson; C J Torrance; F D Lee; R I Russell
Journal: N Engl J Med Date: 1992-09-10 Impact factor: 91.245

8 in total

1. Use of nonsteroidal anti-inflammatory drugs and coxibs in the elderly. Are we following the guidelines?

Authors: Sergio Duran-Barragan; Anthony S Russell
Journal: Clin Rheumatol Date: 2008-07-12 Impact factor: 2.980

Review 2. Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Authors: J Y Jouzeau; B Terlain; A Abid; E Nédélec; P Netter
Journal: Drugs Date: 1997-04 Impact factor: 9.546

Review 3. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors: J C Gillis; R N Brogden
Journal: Drugs Date: 1997-01 Impact factor: 9.546

Review 7. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.

Authors: C R Lee; J A Balfour
Journal: Drugs Date: 1994-12 Impact factor: 9.546

Review 8. Nonsteroidal anti-inflammatory drugs and heart failure.

Authors: Gysèle S Bleumink; Johannes Feenstra; Miriam C J M Sturkenboom; Bruno H Ch Stricker
Journal: Drugs Date: 2003 Impact factor: 9.546